Contraindicated (1)pentobarbital will minimize the level or result of elbasvir/grazoprevir by affecting hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will lessen the extent or influence of vincristine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unfamiliar.

pentobarbital will lessen the extent or influence of fosaprepitant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.

pentobarbital will lessen the level or result of venetoclax by impacting hepatic/intestinal enzyme CYP3A4 metabolism.

pentobarbital will decrease the level or result of acalabrutinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.

pentobarbital will reduce the extent or influence of apremilast by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Coadministration with sturdy CYP inducers brings about an important decrease of systemic publicity of apremilast, which can result in lack of efficacy

pentobarbital will lessen the extent or effect of losartan by affecting hepatic enzyme CYP2C9/10 metabolism. Minimal/Significance Not known.

pentobarbital will lower the extent or outcome of diazepam buccal by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. Robust or reasonable CYP3A4 inducers may well maximize price of diazepam elimination; consequently, efficacy of diazepam could possibly be lessened.

pentobarbital will reduce the extent or result of nisoldipine get more info by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.

pentobarbital will minimize the level or influence of maraviroc by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.

pentobarbital will lower the extent or influence of ramelteon by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Significance Unfamiliar.

pentobarbital will decrease the level or effect of irinotecan by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.

pentobarbital will lower the level or outcome of pimavanserin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe. Stay clear of coadministration if at all possible. Observe for decreased pimavanserin efficacy. An increase in pimavanserin dosage may be desired.

pentobarbital will lessen the extent or impact of repaglinide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.